Q1 2024 Adapthealth Corp Earnings Call Transcript
Key Points
- AdaptHealth Corp reported a 6.2% non-acquired revenue growth and an 18% increase in adjusted EBITDA over the previous year's first quarter.
- The company successfully reduced its leverage ratios and absolute level of debt, aligning with its financial strategy to de-lever.
- AdaptHealth Corp's sleep and respiratory product lines continue to deliver strong results, contributing positively to the company's overall performance.
- The transition of Humana patients is substantially complete, which has started to perform both operationally and financially as initially projected.
- AdaptHealth Corp has appointed a new CEO, Suzanne Foster, who brings over 25 years of healthcare experience, potentially strengthening the company's leadership and strategic direction.
- AdaptHealth Corp faced challenges with the Change Healthcare issues, impacting cash flow and necessitating a draw of $75 million on their revolver.
- The company's diabetes business, despite improvements, still faces challenges and requires further development to fully realize its growth potential.
- There are ongoing supply chain slowdowns in sleep resupply, which could impact growth and operational efficiency in the short term.
- AdaptHealth Corp's pump and pump supply categories experienced revenue pressure due to market shifts towards tubeless pumps.
- The company incurred additional costs due to manual processing required by the Change Healthcare situation, which could affect short-term financial performance.
Good day, everyone, and welcome to today's AdaptHealth first-quarter 2024 earnings release. (Operator instructions)
Today's speakers will be Richard Barasch, Chairman and Interim CEO of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth. Josh Parnes, President of AdaptHealth, will join Richard and Jason for the question-and-answer portion of today's call.
Before we begin, I'd like to remind everyone that statements included in this conference call in the press release issued today may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These statements include, but are not limited to comments regarding financial results for 2024 and beyond. Actual results could differ materially from those projected in forward-looking statements because of a number of risk factors and uncertainties, which are discussed at length in the company's annual and quarterly SEC filings. AdaptHealth Corp. should have no obligation to update the information provided on this call to reflect such subsequent events.
Additionally, on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
